- Welcome to the Institute's new Internet
- Stem cell technique offers new potential to treat blindness
- 20 percent of adult obesity might be caused by infant nutrition
- Study to reduce birth defects
- Beta thalassaemia gene therapy success
- Genetic link with human male infertility identified
- New research into Congenital Toxoplasmosis endorses UK health guidance for pregnant women
- ICH Poster Competition and Open Day
- Is 'breast only' for first six months best?
- Six months of exclusive breast feeding: how good is the evidence?
- Major new programme to tackle childhood obesity launched
- Study shows that early detection of Severe Combined Immunodeficiency would save lives
- £28 Million boost to understand child health
- The impact of sex selection and abortion in China, India and South Korea
- Regenerative medicine success for muscles
- New study examines early-onset eating disorders in under-13s
- International 50-year mortality trends in children and young people reveal an inadequate response to the health problems and causes of death in adolescents, particularly young men
- Apples, oranges and jam – the tasty way to keep kidney disease at bay
- Scientists prove heart has built-in repair mechanism: Exciting breakthrough towards mending broken hearts
- Fight for Sight awards £1 million for retinal disease research
- New Policy Research Unit in the Health of Children, Young People and Families
- UCLB and NCYPE announce a commercialisation agreement with Special Products Limited for Epistatus®
- Molecular scalpel hope for Duchenne muscular dystrophy
- Eating disorders linked to fertility problems and negative feelings towards pregnancy
- Science: From Cradle to Grave
- £36 million boost for children's health research
- Gene therapy success for children born without functioning immune system
- ICH Open Day 2011
- Under 16s make up less than one per cent of NHS patient surveys
- Mitochondria genes and cardiomyopathy
- Child Health Research PhD Studentships 2012-13
- Tate Liverpool exhibition inspires pioneering science games
- No consistent decrease in child maltreatment despite years of policy initiatives designed to achieve it
- New approach on bone marrow transplant infections
- Genetic testing for antibiotic related deafness
- Great Ormond Street Hospital Children’s Charity announces plans to build a Centre for Children’s Rare Disease Research
- Gene therapy shows clinical effect in third immune disease
- Clean delivery kits linked to substantial reduction in neonatal deaths in South Asia, study shows
- Genetic variant inherited from the mother significantly increases birth weight
- Not enough is known about prescription drug use in pregnancy, say experts
- Improving access to education and employment and reducing the risk of transport-related injury are among the best ways to improve adolescent health
- Research reveals association between red hair gene and rare birthmarks
- Five new UCL fellows of Academy of Medical Sciences
- Surgery boost for children with drug-resistant epilepsy.
- Professor of economics and deputy director appointed to the new UK Birth Cohort Study
- First example of a heritable abnormality affecting semantic cognition found
- New Director of the UCL Institute of Child Health
- New approach to recording suspected child abuse in patient records
- Amniotic fluid yields alternatives to embryonic stem cells
- ICH OPEN DAY AND POSTER COMPETITION
- Europe’s first research centre to battle birth defects
- New cause of thyroid hormone deficiency discovered
- £10 million boost for Centre for Children’s Rare Disease Research
- EU awards grant to develop new drug for Duchenne muscular dystrophy
- New research centre for teenagers with arthritis
- Major study shows steep decline in figure for diagnosed epilepsy
- Obesity leads to vitamin D deficiency
- Researchers find gene responsible for rare condition that can lead to melanomas
- ICH research highlights unmet needs of children and young people with cancer and challenges public policy
- Amniotic fluid stem cells repair gut damage
- Developmental delays identified in children with prolonged seizures
- Number of people in UK diagnosed with eating disorders is increasing
- New method strips lungs of old cells in three hours
- Overall child deaths due to injuries are down in the UK
- Aug 13
- Prestigious NIHR Research Professorship awarded to Professor Persis Amrolia
Great Ormond Street Hospital Children’s Charity announces plans to build a Centre for Children’s Rare Disease Research
5 March 2012
Announcement made on Rare Disease Day
Great Ormond Street Hospital Children’s Charity today announces its ambition to raise money to build a Centre for Children’s Rare Disease Research.
The Centre, estimated to cost £66 million to build and equip, will bring together clinical and research expertise from Great Ormond Street Hospital and UCL, in particular the Institute of Child Health. Once opened, the opportunities for children with rare diseases to participate in studies and help doctors and scientists advance understanding of their condition and find effective treatments will increase. Work carried out in the new Centre will mean that the hospital can start to help more children more quickly.
Rare diseases include rare cancers such as childhood cancers, and some other well-known conditions such as cystic fibrosis and muscular dystrophy. Others are less common and may only affect a single person or a handful of people.
75% of rare diseases affect children and 30% of rare disease patients will die before their 5th birthday. There are more than 6,000[i] rare diseases and 1 in 17 people will be affected by a rare disease at some point in their lives[ii]. In the UK, that equates to around 3.5 million people.
Dr Jane Collins, Chief Executive of Great Ormond Street Hospital said: “Rare diseases risk being undiagnosed and therefore untreated. They are also under-researched at present. Although Great Ormond Street Hospital has made some great strides forward, for example with conditions such as x-scid and ADA-scid where we have pioneered an effective gene therapy treatment, much more work needs to be done. Our ambition is to invest in and lead the way in rare disease research and advance understanding and treatments for the benefit of patients at Great Ormond Street Hospital, in the UK and across the world.”
Great Ormond Street Hospital is well placed for a centre of this kind. The hospital’s clinical teams see many children with rare conditions from all over the UK and overseas, across a wide range of clinical specialities. It is the largest recipient of nationally commissioned NHS funding in the country, in recognition of the doctors seeing more children with rare diseases than probably anywhere else in the world.
The hospital’s research partner, the UCL Institute of Child Health, is central to the hospital’s plans. Professor John Tooke, Vice Provost (Health) at UCL said:
“Together, rare diseases represent a major health burden, particularly in childhood. Tackling rare diseases not only provides much needed help for these often neglected conditions but can also provide unique insights into what is happening in more common conditions.
“Recognising the importance of this area, UCL and our Academic Health Science Centre, UCL Partners, are committed to developing our capacity to tackle rare diseases, working with our extensive, nationally commissioned services, partner healthcare organisations and patient groups. A particular focus of our effort is the UCL Institute of Child Health, which has longstanding strengths in this area. The Institute is a key contributor to UCL’s approach to genetic analysis and treatment and currently there are four gene therapy trials running at Great Ormond Street Hospital. Cell therapy and regenerative medicine are other core strengths – for example, the recently publicised children’s stem cell engineered trachea transplant.
“The planned new Centre for Rare Disease Research will help UCL and the ICH realise our full potential to deliver real changes for paediatric patients, who suffer these challenging conditions. A collaborative ethos within and beyond UCL, and profound patient engagement will enhance the impact of the pioneering approaches that will be developed.”
Great Ormond Street Hospital Children’s Charity is delighted that John Connolly (until recently the Global Chairman and Chief Executive of Deloitte) has agreed to Chair the fundraising appeal board. A successful fundraising appeal will lead to the centre opening in 2018.
John Connolly said: “I’m delighted to have been asked to spearhead the appeal on behalf of Great Ormond Street Hospital Children’s Charity. We need to raise £66m to build and equip the Centre, which will be located next to the hospital and the institute. Without these funds the project simply will not happen and the opportunity will be lost.
“I know from personal experience that much more needs to be done to help children with rare diseases and am convinced that The Centre for Children’s Rare Disease Research will make an enormous difference to the health of children who suffer from rare diseases, not just in the UK, but all over the world.
“The scientists and doctors I’ve met from the hospital and institute are just starting to unlock the potential of 21st century medicine. They now know so much more about how the human body works, why it goes wrong and also how they might put it right. But they need our support so that they can grasp the unique opportunity in front of them and accelerate their valuable work to help many more children with many different conditions, some of whom still have little hope of diagnosis or treatment, let alone a cure.”
[ii] Official Journal of European Commission
Page last modified on 05 mar 12 16:24